Global Dermatology Diagnostic Device Market Research Report- Forecast To 2028

Dermatology Diagnostic Device Market Share And Growth Analysis By Diagnostic Device Type (Dermatoscopes, Microscopes, Imaging Devices), By Application (Skin Cancer Diagnostics, Skin Lesion And Others) By End Users (Hospitals, Research Centers, Institutions, And Others) Forecast To 2027

ID: MRFR/MED/1602-HCR | December 2022 | Region: Global | 85 Pages         

Dermatology Diagnostic Device Market

The Dermatology Diagnostic Devices Market is anticipated to achieve a significant CAGR of 19.7%. Also, the market value will further improve and expand up to USD 6.5 Billion in the forecast period 2021-2028.

Segmentation

By Application Dermatitis Psoriasis Skin Cancer Lesion Cellulitis Others
By Diagnostic Devices Biopsy Devices Microscopes Dermatoscopes Others
By End-User Dermatology Clinics Hospitals Others

Key Players

  • Cynosure Inc. (US)
  • Valeant Pharmaceuticals (Canada)
  • V. Genentech Inc. (US)
  • Alma Lasers Ltd. (Israel)
  • Galderma S.A. (Switzerland)
  • Cutera Inc. (US)
  • Michelson Diagnostics Ltd. (UK)
  • Lumenis Ltd. (Israel)
  • Candela Corporation (US)
  • 3Derm Systems Inc.(US)
  • Others

Drivers

  • Rising concerns related to the skin care
  • Advancement of technologies
Speak to Analyst Request a Free Sample

Dermatology Diagnostic Devices Market Overview


The Dermatology Diagnostic Devices Market is anticipated to achieve a significant CAGR of 19.7%. Also, the market value will further improve and expand up to USD 6.5 Billion in the forecast period 2021-2028. The term dermatology means the medical field related to the treatment and diagnosis of skin diseases. The diagnosis is done through microscopic and visual examination. Furthermore, the diagnosis devices are majorly used that enhance the treatment.


Several factors such as the rising condition of skin diseases are promoting the lucrative growth of the Dermatology Diagnostic Devices. It is evaluated that North America will have the largest share. However, the Asia-Pacific region is anticipated to record the fastest growth in the studied forecast period.


COVID-19 Analysis


The coronavirus disease halted the development and growth of the Dermatology Diagnostic Devices Market. It caused the shutdown of various businesses across the world for several months. This has caused the online shift and boosted the market growth significantly. This factor however emerged as a growth factor. However, the resumption of market opening and developments by market players will further improve the market growth.


Market Dynamics


Market Drivers


The increasing technological advancements and increasing cases of skin cancer are the significant drivers. Also, the rising need for diagnostic devices and other growing awareness will further drive the Dermatology Diagnostic Devices Market Growth.


Restraints


The strict regulation policies among various countries can cause slow manufacturing of the products. That’s why this reason is anticipated to restraint the market growth in the future years.


Opportunities


Countries in Asia-Pacific especially India China are anticipated to offer new opportunities. The low labor costs and rising adoption of new technologies will further improve the chances of opportunities for Dermatology Diagnostic Devices Market Growth.


Challenges


Some challenges such as shortage of skilled labor and low awareness for new devices can be challenging for the market in the forthcoming years.


Cumulative Analysis


The Compound Annual Growth Rate (CAGR) of the Dermatology Diagnostic Devices Market is estimated to reach up to 19.7%. It is anticipated that the market value will further improve in the forthcoming years. Therefore, it will expand up to USD 6.5 Billion in the studied forecast period 2021-2028.


Value Chain Analysis


The improvement in the Dermatology Diagnostic Devices Market Tends due to increasing cases of skin diseases mainly skin cancer will have a significant impact on the market growth. Various factors such as improvement in the supply chain and growing development by the key players will eventually enhance the value chain of the market.


Market Segmentations


The segments of the Dermatology Diagnostic Devices Market are divided into application, diagnostic devices, and end-users. Based on application, the market is divided into Dermatitis, Psoriasis, Skin Cancer, Lesion, Cellulitis, and Others. The skin cancer sub-segment is anticipated to lead the market in the upcoming years.


Based on diagnostic devices the Market is divided into Biopsy Devices, Microscopes, Dermatoscopes, and others. It is estimated that the dermatoscopic sub-segment will have lucrative growth in the future years. The rising cases of skin-cancer-related diseases are the crucial reason for this segment.


Based on end-users the Dermatology Diagnostic Devices Market is divided into Dermatology Clinics, Hospitals, and others. The Market Analysis suggests that dermatology clinic sub-segment will significantly in the future years.


Regional Analysis


The Dermatology Diagnostic Devices Market Size based on region is divided into Europe, North America, Asia-Pacific, and the Rest of the World. According to the Dermatology Diagnostic Devices Market Forecast, it is anticipated that the North American region will lead the market with the highest share. The major drivers of this region are the increasing cases of skin cancer and other types of skin diseases such as basal cell carcinoma. Also, the high adoption rate of new technologies and devices for treatment will further improve the market growth.


Furthermore, the European region is evaluated to have the second-largest Dermatology Diagnostic Devices Market Share. The growing emphasis by governments by introducing new policies and investments is the crucial reason for a significant share.


Moreover, the Asia-Pacific region is evaluated to have the fastest growth in the studied forecast period. The significant development in technology and other various aspects in countries such as India and China are fuelling the growth.


After that Rest of the World consists of regions of Latin America, Africa, and the Middle East. The segment of the rest of the world consists of regions of Latin America, Africa, and the Middle East. It is anticipated that the Dermatology Diagnostic Devices Market in this region will boost in the forthcoming years.


Competitive Landscape


The key players are playing a crucial role to improve the Dermatology Diagnostic Devices Market Growth. They do various mergers, partnerships, acquisitions, new ventures, etc. Some of the key players of the Dermatology Diagnostic Devices Market are listed below.



  • Cynosure Inc. (US)

  • Valeant Pharmaceuticals (Canada)

  • V. Genentech Inc. (US)

  • Alma Lasers Ltd. (Israel)

  • Galderma S.A. (Switzerland)

  • Cutera Inc. (US)

  • Michelson Diagnostics Ltd. (UK)

  • Lumenis Ltd. (Israel)

  • Candela Corporation (US)

  • 3Derm Systems Inc.(US)

  • Ambicare Health (US)

  • Solta Medical Inc. (US)

  • Syneron Medical Ltd. (Israel)


Recent Developments



  • 3Derm Systems Inc. in 2020 announces the approval by the FDA for its product called 3DermSpot. This is an algorithm equipped with artificial intelligence and skin images that helps to detect cancer diseases.

  • Lancer Skincare in 2020 launched its first device for skin exfoliation called “Polish Microdermabrasion Device.”


Report Overview


The report overview of the Dermatology Diagnostic Devices Market Outlook is as follows.



  • Market Overview

  • COVID-19 Analysis

  • Dynamics of the Market

  • Value Chain Analysis

  • Market Segmentation

  • Regional Analysis

  • Competitive Analysis

  • Recent Development


Report Score and Segmentation


The report score is to provide valuable information about Dermatology Diagnostic Devices Market Forecast. This report highlights the information regarding CAGR, market value, challenges, recent developments, and many more. The information provided in this report is collected from various secondary and primary sources.



  • Study Period- 2021-2028

  • Base Year-2021

  • Forecast Period- 2021-2028

  • Historical Period-2017-2020


Segmentation


By Diagnostic Devices


  • Biopsy Devices

  • Microscopes

  • Dermatoscopes

  • Others


By Application


  • Dermatitis

  • Psoriasis

  • Skin Cancer

  • Lesion

  • Cellulitis

  • Others


By End-Users


  • Dermatology Clinics

  • Hospitals

  • Others


By Region


  • Europe

  • North America

  • Asia-Pacific

  • The Rest of the World



Report Scope:

Report Attribute/Metric Details
  Market Size   2028: USD 6.5 Billion
  CAGR   2021-2028: 19.7%
  Base Year   2020
  Forecast Period   2021 - 2028
  Historical Data   2019
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   Device type, application and end users
  Geographies Covered   North America, Europe, Asia-Pacific, and Rest of the World (RoW)
  Key Vendors   Valeant Pharmaceuticals (Canada), Alma Lasers, Ltd. (Israel), Cutera, Inc. (U.S.), Lumenis, Ltd. (Israel), Cynosure, Inc. (U.S.), Dino-Lite Europe/IDCP B.V., Genentech, Inc., (US), Michelson Diagnostics Ltd., (UK), Galderma S.A., (Switzerland), and Cutera
  Key Market Opportunities

  • Mergers and acquisitions
  • New product developments
  •   Key Market Drivers

  • Rising concerns related to the skin care
  • Advancement of technologies


  • Speak to Analyst Ask for Customization

    Frequently Asked Questions (FAQ) :

    Advancement of technologies in diagnostic devices and procedures, rising concerns related to the skin care, and awareness about the importance of early diagnosis are the major tailwinds pushing the growth of the global dermatology diagnostic device market.

    The imaging devices segment holds the largest share in the global dermatology diagnostic device market.

    North America holds the largest share in the global dermatology diagnostic device market, followed by Europe and the Asia Pacific, respectively.

    Alma Lasers, Ltd. (Israel), Valeant Pharmaceuticals (Canada), Cutera, Inc. (US), Cynosure, Inc. (US), Lumenis, Ltd. (Israel), Dino-Lite Europe/IDCP B.V. (the Netherlands), Genentech, Inc., (US), Michelson Diagnostics Ltd., (UK), Cutera, Inc. (US), and Galderma S.A., (Switzerland), are some of the major players operating in the dermatology diagnostic device market.

    Strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology/ product launch are some of the growth strategies that players operating in the global dermatology diagnostic device market adopt to gain a larger competitive advantage.